| Ferroptosis, a new form of cell death: opportunities and challenges in cancer | 2019/03/29 | English | 874 |
| Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications | 2019/07/12 | English | 769 |
| The biology and role of CD44 in cancer progression: therapeutic implications | 2018/05/10 | English | 711 |
| Ferroptosis, necroptosis, and pyroptosis in anticancer immunity | 2020/08/10 | English | 661 |
| Targeting the Wnt/β-catenin signaling pathway in cancer | 2020/12/01 | English | 594 |
| The effects of β-glucan on human immune and cancer cells | 2009/06/10 | English | 539 |
| Tumor-associated macrophages: from basic research to clinical application | 2017/02/28 | English | 539 |
| Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers | 2013/02/25 | English | 512 |
| Next generation of immune checkpoint therapy in cancer: new developments and challenges | 2018/03/15 | English | 504 |
| Exosomes in cancer: small particle, big player | 2015/07/10 | English | 503 |
| Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy | 2019/08/28 | English | 498 |
| Targeting mTOR for cancer therapy | 2019/07/05 | English | 480 |
| Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma | 2015/10/29 | English | 469 |
| SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19 | 2020/09/04 | English | 452 |
| Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | 2019/09/05 | English | 436 |
| Nanomaterials for cancer therapy: current progress and perspectives | 2021/05/31 | English | 433 |
| EZH2: a novel target for cancer treatment | 2020/07/28 | English | 415 |
| Wnt/beta-catenin pathway: modulating anticancer immune response | 2017/05/05 | English | 386 |
| Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy | 2019/05/31 | English | 364 |
| The interplay between m6A RNA methylation and noncoding RNA in cancer | 2019/11/22 | English | 349 |
| Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer | 2020/11/19 | English | 348 |
| A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma | 2018/12/01 | English | 339 |
| Role of platelets and platelet receptors in cancer metastasis | 2018/10/11 | English | 336 |
| Mechanism of action of lenalidomide in hematological malignancies | 2009/08/12 | English | 314 |
| Clinical applications of mesenchymal stem cells | 2012/04/30 | English | 308 |
| Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development | 2018/09/19 | English | 306 |
| RETRACTED ARTICLE: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis | 2019/12/09 | English | 303 |
| Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents | 2010/02/04 | English | 296 |
| Long non-coding RNA: a new player in cancer | 2013/05/31 | English | 293 |
| Functions of lncRNA HOTAIR in lung cancer | 2014/12/01 | English | 292 |